Covestro polycarbonate selected for innovative airway monitoring device

A common challenge in mechanical ventilation is maintaining synchrony between a patient’s respiratory demand and the ventilator's delivery of air. Patient-ventilator asynchrony (PVA) occurs frequently and can lead to ventilator-induced lung injury, patient discomfort, and may increase the risk of death.

Certus Critical Care is developing the VentRight Monitor (VRM), an airway monitoring medical device, to improve patient care in critical situations requiring mechanical ventilation. The VRM uses multiple sensors and advanced algorithms to accurately identify multiple types of PVA along with clinical decision support to assist providers in effectively managing these PVAs. By offering precise detection and monitoring, the VRM aims to empower healthcare providers in emergency departments, intensive care units and medical transport with the information needed to optimize patient care in real-time. For this innovative technology, Covestro is supplying Certus Critical Care with its Makrolon® 2458 polycarbonate, used in the water trap and airway chamber. Makrolon® 2458 offers biocompatibility and impact strength with the appearance of glass, which is necessary in critical care environments. Certus Critical Care also has plans for a supporting monitor, which will use Covestro material for its housing.

Makrolon® 2458 polycarbonate is a medical grade thermoplastic material that meets ISO 10993-1 and USP class VI. Available in transparent and translucent colors, this material offers biocompatibility and impact strength with the appearance of glass. Bayblend® M850 XF PC+ABS, a medical grade thermoplastic material, offers rugged durability and high chemical resistance for challenging medical environments.

“The VentRight Monitor is a technological advance that will help answer an unmet need in the healthcare market,” said Mark Nichols, Healthcare Key Account Manager, Covestro LLC. “We are working closely with Certus Critical Care to provide a high-quality, proven material that meets the rigorous requirements of this potentially life-saving product.”

Covestro was selected as a partner because of its reputation for producing high-quality, durable engineering plastics, according to Certus Critical Care. ”Their materials not only met but exceeded our needs for durability, resistance to sterilization processes, and compliance with biomedical standards,” said Jared Spendlove, Director of Operations and Manufacturing, Certus Critical Care.

“Utilizing Covestro's materials allowed us to design a product capable of withstanding the demanding conditions of critical care environments, providing a reliable tool for healthcare professionals, and setting a new standard in patient-ventilator monitoring.”

Attendees at MD&M West, February 6-8 in Anaheim, California, can visit the Covestro booth (#2221) to learn how the company’s materials are pushing boundaries in healthcare applications.

About Covestro:

Covestro is one of the world’s leading manufacturers of high-quality polymer materials and their components. With its innovative products, processes and methods, the company helps enhance sustainability and the quality of life in many areas. Covestro supplies customers around the world in key industries such as mobility, building and living, as well as the electrical and electronics sector. In addition, polymers from Covestro are also used in sectors such as sports and leisure, cosmetics and health, as well as in the chemical industry itself.

The company is committed to becoming fully circular and is striving to become climate neutral by 2035 (scope 1 and 2). Covestro generated sales of EUR 18 billion in fiscal 2022. At the end of 2022, the company had 50 production sites worldwide and employed approximately 18,000 people (calculated as full-time equivalents).

Find more information at the www.covestro.us or read the Case Study.
Read our Corporate Blog.

Makrolon® and Bayblend® are registered trademarks of Covestro Group.

Forward-Looking Statements 

This news release may contain forward-looking statements based on current assumptions and forecasts made by Covestro AG. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Covestro’s public reports which are available at www.covestro.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. 

Editor’s Note: 

Follow news from Covestro on Twitter: https://twitter.com/CovestroUS